A fter some viral infections, virus-specific CD8
+ T cells often fail to differentiate into memory CD8 + T cells and rapidly lose their ability to lyse virally infected cells (1, 2) . Loss of T cell responses to terminate infection is termed CD8 + T cell exhaustion (3) . Programmed cell death-1 (PD-1) is implicated as a major cell surface inhibitory receptor capable of regulating virus-specific CD8 + and CD4 + T cell exhaustion in mice, and in primates and humans during chronic virus infection (4) (5) (6) (7) . Blockade of the PD-1 signaling pathway in chronically infected mice rescues function of exhausted T cells (8, 9) . PD-1 is also induced on tumorinfiltrating T cells, and blockade of PD-1 increases tumor-specific T cell proliferation and function, suggesting that PD-1 signaling may result in human tumor-specific T cell exhaustion (9, 10) .
PD-1 ligand (PD-L1; B7-H1, CD274), a cell surface glycoprotein, belongs to the B7 family of costimulatory molecules and is expressed on activated dendritic cells (DCs), macrophages (MFs), T cells, B cells, and monocytes (4, (10) (11) (12) , as well as on human carcinomas of lung, ovary, and colon, and in melanomas (13) . PD-L1 is upregulated on myeloid DCs during virus infection (14) and contributes to poor control of chronic infections in mice (8) and humans, including HIV-1 (6, 15) . PD-1/PD-L interactions regulate peripheral self-reactive CD8 + T cell tolerance on encounter with DCs bearing self-antigen (16, 17) . PD-L1 promotes differentiation and maintains function of induced regulatory T cells (Tregs) by enhancing Foxp3 expression in Tregs (18) . PD-L1 expression levels on myeloid DCs correlate with poorer cancer prognosis (19, 20) . Blockade of PD-1/PD-L1 interaction increases infiltration of CD8 + T cells to tumors (9) , suggesting that PD-L1 induction is associated with tumor-specific T cell exhaustion (21) . Myeloid-derived suppressor cells (MDSCs), described as CD11b + GR-1 + cells in mice, suppress T cells in various cancer models (22) (23) (24) (25) . MDSCs recruited by tumors contribute to tolerance of antitumor CD8 + T cell responses to evade antitumor immunity (22) (23) (24) (25) . M-CSF is an important cytokine that promotes differentiation from DCs toward MFs and contributes to differentiation of MDSCs (21, 26, 27) . MDSCs are abundant in local tumor environments, especially those enriched with M-CSF, which affect the suppressive capacity of MDSCs to tumor Agspecific T cell immunity and possibly trigger PD-L1 expression (9, 21) . However, whether PD-L1 plays a role in MDSC-mediated T cell suppression remains controversial (9, 28, 29) . PD-L1 is known to be expressed on Gr-1 + CD11b + MDSCs obtained from mice bearing tumor (9, 30) , but in some reports, PD-L1 expression was not found on MDSCs (31) . This may be because of differences in tumor-derived factors, which may regulate expression of PD-L1 on MDSCs. In fact, MDSCs are composed of a heterogeneous population of myeloid cells, including monocytes/MFs, and DCs at different stages of differentiation (22) .
IL-10 is a potent immunosuppressive cytokine that inhibits the ability of DCs to mature into functional APCs that have low-level secretion of proinflammatory cytokines and expression of costimulatory receptors (25, 32) . IL-10 is often increased in persistent infections in mice and humans (15, 33) , and is implicated in impaired T cell response to chronic viral infections (32) (33) (34) . Consistent with this, IL-10R blockade increases proliferative capabilities of HIV-and HCV-specific T cells (35, 36) . IL-10 upregulates PD-L1 expression on peripheral blood CD14 + monocytes (15, 37) , and PD-L1 upregulates IL-10 production (32, 38) as part of an immunosuppressive circuit. IL-10 and PD-L1 may cooperate to promote exhaustion of CD8 + T cells probably in synergy during persistent viral infections (15, 32, 39) . Thus, IL-10 may be involved in switching functional properties of immunogenic DCs to tolerogenic DCs through mediation of PD-L1 signaling.
Although PD-1/PD-L1 signaling, IL-10, and MDSCs are important central immune suppressive mediators, the mechanisms by which the suppressive signaling pathways merge to execute exhaustion processes, particularly in CD8 + T cells, remain elusive. We previously demonstrated that M-CSF-derived DCs (M-DCs) were tolerogenic to CD4 + T cells (40) . Unlike GM-CSF-derived DCs (GM-DCs), M-DCs produce high levels of IL-10, but not IL-12. IL-10-producing MFs preferentially take up apoptotic cells (41) . This prompted us to postulate that M-CSF and IL-10 may instruct human CD14 + monocytes to an immune tolerance program by inducing PD-L1 for CD8 + T cell immune responses. We identify a novel subset of M-DCs with phagocytic activity, particularly in the presence of IFN-g, an proinflammatory cytokine. Phagocytosis is dependent on PD-L1. Our results demonstrate that phagocytosis by tolerogenic DCs, mediated by PD-1/PD-L1 interaction, adds another dimension to CD8 + T cell tolerance.
Materials and Methods

Reagents
Recombinant human IL-15, IL-4, and M-CSF were purchased from PeproTech (Rocky Hill, NJ). rGM-CSF was obtained from BioVision (Exton, PA). LPS from Salmonella minnesota was purchased from Sigma-Aldrich. PD-1-PE (clones J105 and MIH4), anti-PD-L1-PE, anti-PD-L1-PE-Cy7 (clone MIH1), anti-PD-2 ligand (PD-L2)-PE (clone MIH18), anti-CD80 (clone 2D10.4), purified neutralizing anti-PD-L1 (clone MIH1), and corresponding isotype controls were purchased from eBioscience (San Diego, CA). Anti-PD-1-allophycocyanin (clone MIH4), anti-CD14-FITC, anti-CD86-PE-Cy5, and anti-CD11c-allophycocyanin were purchased from BD Pharmingen (Franklin Lakes, NJ). Anti-CD8-PE-Cy5.5 and ProLong Gold antifade reagent with DAPI were purchased from Invitrogen (Carlsbad, CA). In vitro generation of DCs CD14 + monocytes (5 3 10 5 cells/ml) were cultured in RPMI 1640 medium (BioWhittaker) supplemented with 10% heat-inactivated FBS (HyClone Laboratories), 2 mM L-glutamine, 55 mM 2-ME, 100 U/ml penicillin, and 100 mg/ml streptomycin and 20 ng/ml IL-4 for 5 d in the presence of either recombinant human M-CSF (20 ng/ml) or 400 U/ml recombinant human GM-CSF to respectively generate M-DCs and GM-DCs. A total of 20 ng/ml IL-10 was included in M-DC and GM-DC generation cultures to produce IL-10-stimulated M-DCs (M-DC/IL-10) and IL-10-stimulated GM-DCs (GM-DC/IL-10), respectively. In some cases, 50 ng/ml TNF-a (PeproTech) was added to the M-DC/IL-10 generation cultures. Half of culture medium was changed every 3 d, unless otherwise indicated. M-DC/IL-10 and GM-DC/IL-10 were further cultured for an additional 4 d with or without IFN-g at 50 ng/ ml to generate IFN-g-stimulated M-DC/IL-10 (M-DC/IL-10/IFN-g) and IFN-g-stimulated GM-DC/IL-10 (GM-DC/IL-10/IFN-g), respectively.
Coculture of DCs and CD8 + T cells
DCs harvested on day 5 were placed in 96-well flat-bottom plates (1 3 10 4 cells in 100 ml medium; Costar, Corning, NY). Before coculture with DCs, CD8 + or CD4 + T cells (1 3 10 6 cells/ml) were incubated for 5 d in complete RPMI 1640 medium supplemented with 10 ng/ml IL-15. IL-2 (100 U/ml) was added to CD4 + T cell cultures in addition to IL-15 to maintain cell viability. In some cases, CD8 + T cells were cultured in IL-15 (20 ng/ml) for 5 d with or without dexamethasone (10 27 M) or anti-CD3 coated to culture plates at 0.1 mg/ml. DCs were mixed with allogeneic CD8 + T cells preincubated for 5 d in IL-15 and cultured for an additional 4 d in 20 ng/ml IL-15, 20 ng/ml M-CSF, and 20 ng/ml IL-10 in complete RPMI in the absence or presence of 50 ng/ml IFN-g. CD8 + T cells were stained with CFSE (10 mM) in PBS before being mixed with DCs. Cells in cocultures were examined under the microscope or harvested for flow cytometric analysis for expression of surface markers. In some cases, cell cultures were carried out on glass slides for observation under confocal microscopy.
Flow cytometric analysis
Harvested cells were washed with PBS supplemented with 1% BSA. FcRs on cells were preblocked with excess human IgG (Sigma-Aldrich) on ice for 15 min. Cells were stained for 30 min at 4˚C with the following FITC-conjugated Abs: anti-CD14 (BD Pharmingen, San Diego, CA); PE-conjugated Abs: PD-1 (J105 and MIH4; eBioscience), PD-L1 (MIH1; eBioscience); PE-Cy7-conjugated Ab: PD-L1 (MIH1; eBioscience), PECy5-conjugated CD86 (BD Pharmingen, CA); PE-Cy5.5-conjugated Ab: CD8 (Invitrogen, CA); and allophycocyanin-conjugated Abs: CD11c (BD Pharmingen, CA), PD-1 (MIH4; BD Pharmingen, CA), or isotype controls (eBioscience). CD8 + T cells and DCs in coculture were analyzed using gating process for CD8 + and CD11c + cells, respectively. CFSE-stained CD8 + T cells and fluorescence in DCs were analyzed at channel 1 (FL1). Apoptosis of CD8 + T cells after culture with or without M-DC was measured by staining with Annexin V-allophycocyanin. Cells were acquired with FACSCalibur (BD Sciences, CA), and data were processed with FCS Version 3 software (De Novo Software, Los Angeles, CA).
Confocal microscopy
DCs cocultured with T cells for 2-4 d were allowed to adhere to glass slides (Lab-Tek Chamber Slide; Nunc, Rochester, NY), washed with PBS to remove loosely bound T cells, and then fixed in 4% paraformaldehyde in PBS for 10 min at room temperature. Cells were then stained with DAPI and mounted with ProLong Gold antifade reagent (Invitrogen, Eugene, OR). Fluorescence analysis of cells was performed using the Zeiss LSM 510 confocal laser scanning system (Carl Zeiss, Heidelberg, Germany) at 1003 magnification. 
Statistical analysis
A two-tailed paired Student t test (unless otherwise indicated) was used to determine statistical significance. The p values ,0.05 were considered significant.
Results
DCs derived by a combination of M-CSF and IL-10 increase PD-1 expression on CD8 + T cells on coculture
We previously demonstrated that M-DCs showed tolerogenic potential to allogeneic CD4 + T cell proliferation. M-DCs were characterized by their ability to secrete IL-10 at high levels but not IL-12, on LPS stimulation (40) . However, whether M-DCs act as suppressor cells to CD8 + T cell functions has not been examined. PD-1 is involved in suppressing CD8 + T cell response to chronic infection and tumor (5, 42) . We were interested in determining whether M-DCs affect PD-1 expression on CD8 + T cells, because no specific type of APCs or DC subsets have been identified as being responsible for inducing PD-1 expression on CD8 + T cells. Although IL-10 is induced during chronic infection and has been reported to be a potential factor for PD-1-mediated viral persistence, there is no clear understanding of the specific cells responsible for inducing PD-1 on CD8 + T cells. + T cells to .20% as a result of coculture (Fig. 1A, 1B ). This was in contrast with M-DC, which had little effect on PD-1 expression on CD8 + T cells. GM-DCs and GM-DC/IL-10 generated in the same way as M-DCs or M-DC/IL-10, but with GM-CSF instead of M-CSF, did not enhance PD-1 expression on CD8 + T cells (data not shown). We then determined whether the presence of IFN-g and IL-4, type 1 and 2 cytokines, respectively, and TNF-a, a proinflammatory cytokine, influence M-DC/IL-10 effects on PD-1 expression of cocultured CD8 + T cells. The Journal of ImmunologyIFN-g enhanced M-DC/IL-10 effects on PD-1-expressing CD8 + T cells (Fig. 1A, 1B) . Notably, presence of IL-4 or TNF-a during M-DC/IL-10 generation abrogated the enhancing effect of M-DC/ IL-10 on percentage PD-1 expression. Our results suggest that M-DC/IL-10 may be an important mediator cell population limiting IFN-g-producing CD8
+ T cell responses. We next assessed whether increased percentage of PD-1 expression on CD8 + T cells by coculture with M-DC/IL-10 and M-DC/IL-10/IFN-g was due to soluble factors secreted from these DCs. This was done by culturing CD8 + T cells with conditioned media collected from DC cultures at the 5th day of culture. Conditioned media from neither M-DC/IL-10 nor M-DC/IL-10/IFN-g increased percentage of PD-1-expressing CD8 + T cells (Fig. 1C) . M-CSF and IL-10, in the absence of DCs, did not affect percentage of PD-1-expressing CD8 + T cells (data not shown). This suggests that contact with M-DC/IL-10 was responsible for induction of PD-1 expression on IFN-g-producing CD8
+ T cells. This indicates that IL-10 is important for inducing PD-1 on CD8 + T cells, but the effect is mediated through M-DC/IL-10.
IFN-g induces PD-L1 expression at a high level on M-DC only after IL-10 stimulation
Because M-DC/IL-10 are unique in ability to enhance PD-1 expression on CD8 + T cells, we investigated whether M-DC/IL-10 in comparison with M-DC expressed PD-L1 (Fig. 2) . DCs generally express costimulatory or coinhibitory molecules after DCs mature. We found that M-DC/IL-10 expressed higher levels of PD-L1 (34.5%) on the cell surface compared with M-DC (12.3%). PD-L1 expression levels were remarkably increased to 93.7% when M-DC/IL-10 were stimulated with IFN-g for an additional 4 d. In contrast with M-DC/IL-10, M-DC failed to respond to IFN-g as much as M-DC/IL-10, with only a slight increase in PD-L1 expression from 12.3 to 20.6%. GM-DC/IL-10/IFN-g expressed a high level of PD-L1 expression (72.8%), but it was slightly lower than for M-DC/IL-10/IFN-g. The results suggest that IFN-g is a potent inducer of PD-L1, and IL-10 acts as a key mediator for a maximal response to IFN-g.
M-DC/IL-10 are unique for low CD86 and high CD14 and CD200R expression Because M-DC/IL-10 induced PD-1, a coinhibitory receptor on cocultured CD8
+ T cells, we investigated whether M-DC/IL-10 differed from M-DC in expression of costimulatory receptors such as CD86, which is important for T cell activation. We found that M-DC/IL-10 expressed CD86 at much lower levels (26.1%) compared with M-DC (74.1%) (Fig. 3A) . In contrast, M-DC/IL-10 maintained higher levels of CD14 (96.5%) than M-DC (47.6%). The expression levels of CD14 on M-DC/IL-10 levels are comparable with those on MFs developed by M-CSF without IL-4 from CD14 + monocytes. IFN-g reduced levels of CD86 expression on M-DC/IL-10 (3.9%), whereas maintaining high levels of CD14 expression. In contrast with IFN-g, LPS, known to promote maturation of MFs and DCs, increased expression of CD86 on M-DC/IL-10 (M-DC/IL-10/LPS) from 26.1 to 76.7%, reducing CD14 expression. This indicates that although both IFN-g and LPS are considered to be proinflammatory, IFN-g is unique in its inhibitory effects on CD86 expression on M-DC/IL-10. Therefore, a phenotype of M-DC/IL-10/IFN-g with little expression of costimulatory CD86 but high expression of coinhibitory PD-L1, as shown in + T cell immune responses, and thus acts as an inhibitory receptor (43) . Consistent with this, CD200 expression on malignant cells is correlated with poor prognosis (44) . Thus, we compared expression levels of CD200R on M-DC, M-DC/IL-10, and M-DC/ IL-10/IFN-g with that on prototype MFs and conventional DCs (referred to as GM-DC in this article) developed in vitro by M-CSF and GM-CSF plus IL-4, respectively. Modest levels of CD200R were detected on MFs and GM-DCs at 16.3 and 15.2%, respectively, when estimated by MFI (Fig. 3B) . Relatively higher levels of CD200R were expressed on M-DCs (at 36.3%) compared with MFs and GM-DC. Even higher levels of CD200R expression were observed in M-DC/IL-10 and M-DC/IL-10/IFN-g (at 87.8 and 84.7%, respectively). Because CD200R is involved in tolerogenic activities by specific subsets of MFs and DCs (45, 46) , high expression of CD200R on M-DC/IL-10 and especially on M-DC/IL-10/IFN-g may relate to the tolerogenic nature of these cells. There are additional ligands for PD-1, such as PD-L2 and CD80 (4). Although PD-L2 and CD80 were expressed only at marginal levels, 7.7 and 18.7%, respectively, on M-DC/IL-10, they were increased to 34.6 and 70.3%, respectively, on M-DC/IL-10/ IFN-g, as shown in Fig. 3C , indicating that IFN-g acts as an important factor for inducing PD-L2 and CD80, as well as PD-L1. + T cell apoptosis (Fig. 5C ). Based on these results, we suggest that M-DC/ IL-10/IFN-g are able to phagocytose CD8 + T cells, and that PD-L1 induced by IFN-g may be involved, at least in part, in this phagocytic activity. These phenomena were unique for M-DC/IL- 
Quantification of phagocytic activities by flow cytometry
We undertook flow cytometric analysis for M-DC, M-DC/IL-10, and M-DC/IL-10/IFN-g cocultured with CFSE-stained CD8 + T cells to quantitatively confirm an IFN-g-inducing effect on phagocytic activity. Cells were stained with CD11c and CD8, and CFSE intensities of CD11c + DCs were assessed by flow cytometry (Fig. 6A) . Low levels of CFSE were detected in M-DC and M-DC/ IL-10 cocultured with CFSE-stained CD8 + T cells (6.5 and 21.9%, respectively; Fig. 6A ). In agreement with our previous microscopic observations, significantly increased levels of CFSE were found in the M-DC/IL-10/IFN-g cells cocultured with CFSEstained CD8 + T cells (42.9%). Controls represent M-DC cultured with CFSE-stained CD8 + T cells. Results were statistically evaluated as shown in Fig. 6B . We assessed whether CD8 + and CD4 + T cells were equivalently subjected to phagocytic activity by M-DC/IL-10/IFN-g (Fig. 6C) . The M-DC/IL-10/IFN-g cells cocultured with CFSE-stained CD4 + T cells showed significantly lower levels of CFSE compared with those with CD8 + T cells (23.4 versus 47.0%). In agreement with our previous results, neutralizing anti-PD-L1 markedly reduced CFSE in M-DC/IL-10/ IFN-g cocultured with CFSE-stained CD8 + T cells from 47.0 to 20.7% (Fig. 6C, 6D (Fig. 4B) . However, CD8 + T cells pretreated with dexamethasone, which would induce apoptosis and possibly attenuate INF-g production, were rendered less efficiently phagocytosed by M-DC/IL-10 compared with nontreated CD8 + T cells. In contrast, anti-CD3 pretreated CD8 + T cells were more efficiently phagocytosed by M-DC/IL-10 than control CD8 + T cells (Fig. 7A) , indicating the importance of preactivation of CD8 + T cells for them to be phagocytosed. These two lines of evidence suggest that timely apoptosis of previously activated CD8 + T cells on encounter with M-DC/IL-10 is necessary, but CD8 + T cells already predestinated for apoptosis may not be critical for their phagocytosis by M-DC/IL-10. High-level expression of PD-1 is detected on chronically activated CD8 + T cells (42) . Thus, our view may explain a potential mechanism for PD-1-mediated exhaustion of previously activated CD8 + T cells. It was not easy to estimate exact numbers of accumulated CD8 + T cells taken up by M-DC/IL-10 during a 5-d coculture, mainly because the phagocytosed CD8 + T cells did not remain intact enough to be counted. Because M-DC/IL-10 gained MFI as a result of phagocytosis of green fluorescent CFSE + CD8 + T cells, we attempted to estimate numbers of CD8 + T cells taken up by M-DC/IL-10 in the presence of INF-g using cytometric analysis for MFI. Based on the assumption that CD8 + T cell volume was ∼1/ 27 of M-DC based from our microscopic observation of the diameter of a CD8 + T cell being ∼1/3 that of M-DC, we estimated the numbers of CD8 + T cells phagocytosed by using methods described in Materials and Methods. Our results showed that ∼1.3 and 10.3 CD8 + T cells were phagocytosed by M-DC/IL-10/INF-g, respectively, at CD8 + T cell/M-DC ratios of 2 and 20. In summary, we demonstrate that PD-1 expression is induced on CD8 + T cells on coculture with M-DC/IL-10 or M-DC/IL-10/ IFN-g cells that were developed from human CD14 + monocytes in vitro by a combination of IL-4, M-CSF, IL-10, and IFN-g. We also found that M-DC/IL-10/IFN-g, which express high levels of PD-L1, act as phagocytic cells for CD8 + T cells and, to a lesser extent, CD4 + T cells. Inhibition of phagocytosis by neutralizing anti-PD-L1 indicates that PD-1/PD-L1 interaction mediates this phagocytic activity. This study suggests a role for M-DC/IL-10 cells in downmodulating CD8 + T cell function in response to IFN-g by phagocytosis, as modeled in Fig. 8 .
Discussion
It is well accepted that DCs can induce tolerance, as well as immunity, but underlying mechanisms for induction or tolerance of immunity by DCs remain unclear. Immature, or alternatively differentiated, DCs are probably primary cells for tolerance responses. T cell exhaustion is defined as gradual loss of effector functions, finally resulting in deletion of virus-specific T cells (39, 42) . Loss of functional CD8 + T cell response to persistent viral + T cells to initiate apoptosis and consequently phagocytic response. Phagocytosis was significantly decreased by neutralizing anti-PD-L1. This indicates that elevated PD-L1 expression on M-DC/IL-10 by IFN-g plays an important role in eliciting phagocytic activity (Figs. 5, 6 ). Thus, the local cytokine micromilieu, enriched with M-CSF and IL-10, may control functional differentiation of DCs from immunostimulatory to tolerogenic cells targeting IFN-g-producing CD8
+ T cells for phagocytosis. Although PD-1 acts on both CD4
+ and CD8 + T cell populations as a coinhibitory receptor (51), CD8 + T cells were more susceptible, compared with CD4 + T cells, in response to phagocytosis (Fig. 6C, 6D ). This may be because CD8 + T cells express PD-1 more readily or respond to PD-L1 more sensitively compared with CD4 + T cells. Our results emphasize the importance of IFN-g, a proinflammatory cytokine, for phagocytic clearance of CD8 + T cells as an additional level of CD8 + T cell tolerance. IFN-g is a proinflammatory cytokine produced mainly by type 1 effector T cells and is required for CD8 + T cell cytotoxic functions. Thus, it seems paradoxical that phagocytic deletion of CD8 + T cells depends on IFN-g. We believe that IFN-g is important not only for type 1 effector T cell immune responses, but also for clearing effector CD8 + T cells by MDSC. Therefore, the phagocytic activity we observed in this study may take place in vivo to keep IFN-gproducing CD8
+ T cells in check to prevent excessive or continuous immune responses. TNF-a failed to develop phagocytic activity in M-DC/IL-10 cells, but instead induced cell death (data not shown). In mouse models, IFN-g has been reported to negatively regulate CD8 + T cell response by promoting cell death mediated by PD-1, and blockade of IFN-g augments the severity of graft-versus-host disease in allogeneic hematopoietic cell transplantation (52, 53) . Furthermore, other mouse systems show that IFN-g plays immunosuppressive roles in conjunction with MDSCs (24, 54) .
Our study does not determine whether M-DC/IL-10 are relevant to certain DC subtypes in mice that show suppressive effects on CD8 + T cell. In a mouse model, treatment of animals with neutralizing anti-PD-L1 did not eliminate or reduce Gr-1 + CD11b
+ MDSC-induced CD8 + T cell tolerance (28) , suggesting that PD- L1 is not required for MDSC-mediated CD8 + T cell immune suppression. Therefore, the MDSCs identified as Gr-1 + CD11b
+ cells in the mouse may not be relevant to the M-DC we generated from human CD14 + monocytes in vitro. In another mouse study (29) , it was reported that IFN-g-stimulated monocyte-derived cells could suppress T cell immune responses by killing activated CD4 + T cells. However, this suppressive activity was accomplished by a caspase-dependent, but PD-1/PD-L1-independent, mechanism. However, phenotypes of the mouse IFN-gstimulated monocyte-derived cells were similar to those of our M-DC/IL-10/IFN-g cells with high expression of PD-L1 and CD14. Thus, it would be of interest in the future to explore the possibility that M-DC/IL-10/IFN-g cells may use caspase to promote apoptosis and/or phagocytosis of CD8 + T cells as seen in our study. The mouse IFN-g-stimulated monocyte-derived cells were also shown to convert cocultured T cell populations to CD4 + CD25 + Foxp3 + regulatory cells (29) . We have previously demonstrated that M-DC were able to suppress CD4 + T cell proliferation (40) , but it remains unclear whether M-DC have a capacity to generate CD4 + FOXP3 + Tregs. Prior IL-10 stimulation was critical for IFN-g to be effective for developing phagocytic activity in M-DC/IL-10. In fact, IL-10 and IFN-g are considered to play opposite roles, as anti-inflammatory and proinflammatory cytokines, but they may cooperate to elicit phagocytic activity against CD8 + T cells via M-DC, as long as IL-10 precedes IFN-g stimulation. An important role of IL-10 in these processes is to block maturation of DCs (25) , as shown in Fig. 3A . Importantly, immaturity of M-DC/IL-10 resulting from exposure to IL-10 may be an important conditioning event for subsequent IFN-g to elicit phagocytic activity in M-DC/IL-10, indicating that strict sequential pathways starting from antiinflammatory to inflammatory cytokine stimulation may be crucial for development of phagocytic DCs. The IL-10 effect depended on M-CSF for developing phagocytic activity. GM-DCs after IL-10 and IFN-g stimulation showed little phagocytic activity even though they expressed relatively high levels of PD-L1.
Thus, M-CSF and IL-10 are required for guiding the direction of DC maturation from peripheral CD14 + monocytes to phagocytic DCs, rather than to immunostimulatory DCs. M-DC/IL-10 cells may be locked in as tolerogenic DCs at this stage and may be unable to convert to immunogenic DCs even in the presence of IFN-g. This idea is supported by high expression of CD200R on MFs, which delivers negative regulatory signals to induce tol- Our confocal microscopic images indicate that many CD8 + T cells remain associated with M-DC/IL-10 even after washing the glass slides with PBS, especially in the presence of IFN-g during the coculture (Fig. 5C) . Moreover, IFN-g increased many fluorescent speckles in M-DC/IL-10 cells cocultured with CFSEstained CD8 + T cells, presumably derived from CFSE-stained CD8 + T cells. We noticed many vacuoles created on the surface of M-DC/IL-10 only when both CD8 + T cells and IFN-g were present (Fig. 5B ). Many these vacuoles appeared to be occupied by CD8 + T cells. This suggests that CD8 + T cells may be directly involved in creating the vacuoles. Exhausted CD8 + T cells may continue to produce IFN-g (3) , and the final fate of the IFN-gproducing CD8
+ T cells expanded by chronic virus infection is unclear. The symptomatic CD8 + T cell exhaustion by HIV, as well as other infections, is mainly attributed to PD-1 and IL-10 (32). In a mouse model, IFN-g is known to attenuate graft-versus-host disease, promoting CD8 + T cell exhaustion (52) . Our results suggest that M-DC/IL-10/IFN-g may be involved in causing CD8 + T cell exhaustion, as seen in HIV and other virus infections, perhaps by phagocytosing exhausted CD8 + T cells.
